Contents
On this page
- Distinctions between limitations-focused and standard effectiveness reviews
- The documented motor and non-motor coverage gap in Parkinson’s disease monitoring
- Divergence between sensor data and clinical meaning
- Suitability of scoping review methods for limitations-focused questions
- A framework for structuring a limitations-focused review
- Documented gaps in care integration and telehealth delivery
- Reporting gap findings in a usable form
Academy · Research Data, Analytics & AI · Reviewing Technology Limitations
Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring
A 2016 Movement Disorders review found that wearable sensors for Parkinson’s disease had been validated almost entirely on motor symptoms such as tremor and gait, leaving non-motor problems such as sleep and mood under-measured. This gap illustrates the type of coverage bias that a limitations-focused systematic review should identify.
A systematic review of the limitations of a technology is a specific form of evidence synthesis: rather than asking whether a technology works, it asks where the existing evidence base falls short, which use cases are well validated, which are assumed rather than tested, and which populations or outcomes the literature has largely neglected. This analytical task differs from that of a standard effectiveness systematic review and requires its own explicit framework for what constitutes a “gap” worth reporting. The literature on wearable sensor technology for monitoring Parkinson's disease is a well-documented case: multiple reviews have found that the evidence base is concentrated almost entirely on motor symptoms, whereas non-motor problems that patients themselves rate as highly burdensome have received comparatively little rigorous monitoring research, a pattern that illustrates what a limitations-focused review is designed to detect and report.
Learning objectives
- How a limitations-focused systematic review differs in scope and method from a standard effectiveness review
- The documented coverage gap between motor- and non-motor-symptom monitoring in the Parkinson's disease wearable-sensor literature
- A practical framework (coverage, validity, and population gaps) for structuring this kind of review
Common misconceptions
- “A systematic review of a technology's 'limitations and challenges' is just a standard systematic review with a pessimistic title.” Reviews of Parkinson's disease monitoring technology, including Espay and colleagues' 2016 analysis in Movement Disorders, define a specific coverage gap as their central finding: wearable systems have been validated almost entirely against motor symptoms such as tremor, gait, and bradykinesia, while non-motor symptoms like sleep disturbance, fatigue, and mood are both common and under-measured, which is a structural claim about the evidence base itself, not a summary of individual studies' effect sizes.
Distinctions between limitations-focused and standard effectiveness reviews
A standard systematic review of a clinical technology typically poses a PICO-style (population, intervention, comparator, outcome) question: for a given population, does this intervention improve a given outcome compared with a comparator1. A limitations-focused review poses a structurally different question: it asks what has been tested across the existing body of studies, in whom and against what reference standard, and at what point the literature ends. This requires the extraction of a different set of variables from each included study: not only effect estimates, but also the outcome domain measured, the population characteristics represented, the comparator or validation standard used, and what the study explicitly did not attempt to measure. The PRISMA 2020 statement's guidance on synthesis methods explicitly supports this kind of structured mapping, noting that reviews aiming to characterize a body of evidence rather than pool a single effect size should report their synthesis methods and the specific gaps identified with the same rigor as a quantitative meta-analysis2.
The documented motor and non-motor coverage gap in Parkinson’s disease monitoring
Espay and colleagues' 2016 review in Movement Disorders examined the state of technology for the assessment of Parkinson's disease and found that wearable and sensor-based systems had concentrated almost entirely on quantifying motor signs (tremor amplitude, gait parameters and bradykinesia), because these are comparatively straightforward to capture with accelerometers and gyroscopes and have established clinical rating scales against which they can be validated3. Non-motor symptoms, including sleep disturbance, fatigue, orthostatic hypotension, anxiety and depression, are reported by patients as comparably burdensome to motor symptoms, yet the review found considerably fewer validated unobtrusive monitoring approaches for them, partly because many of the standard reference measures for non-motor symptoms are laboratory-based or questionnaire-based rather than continuously measurable at home3. A separate systematic review of monitoring technology characteristics and validity reached a consistent conclusion, finding that the great majority of validation studies for wearable Parkinson's disease technology addressed motor outcomes, with day-to-day variability in non-motor domains left largely untracked across the studies reviewed4.
Divergence between sensor data and clinical meaning
A second, related limitation documented in this literature is that, even for well-studied motor outcomes, sensor measurements do not always correspond closely to the clinical construct they are intended to capture. Maetzler and colleagues' review of quantitative wearable sensors for Parkinson's disease noted that a single sensor placed on one body region captures movement only at that site, which may diverge from a patient's overall functional status or quality of life, and that slowness caused by bradykinesia often cannot be distinguished from slowness caused by fatigue or fear of falling on the basis of accelerometer or gyroscope data alone5. A review focused specifically on remote monitoring during activities of daily living reached a similar conclusion, reporting that validation studies conducted under controlled, structured clinical conditions often do not generalize well to the considerably noisier movement patterns recorded during ordinary daily activity, which constitutes a limitation distinct from, and separately reportable from, the motor/non-motor coverage gap6.
Suitability of scoping review methods for limitations-focused questions
Because a limitations-focused question asks what has and has not been studied, rather than pooling a single quantitative effect, it is frequently better suited to scoping review methodology than to a conventional systematic review built around a narrow PICO question. Tricco and colleagues' 2018 PRISMA extension for scoping reviews, PRISMA-ScR, was developed specifically for reviews that aim to map the breadth of evidence on a broad topic, identify gaps, and clarify key concepts, rather than to answer a single, narrowly bounded effectiveness question, and it provides its own 20-item reporting checklist adapted from the core PRISMA structure7. A review of the limitations of Parkinson's disease monitoring technology could reasonably be conducted and reported either as a systematic review with an explicit gap-analysis synthesis or as a scoping review under PRISMA-ScR; the choice depends on whether the authors also intend to formally assess the risk of bias of each included study (more consistent with a systematic review) or primarily to characterize the breadth and distribution of the existing evidence (more consistent with a scoping review), and this choice should be made and justified at the protocol stage rather than retrospectively, once the included studies are available.
A framework for structuring a limitations-focused review
On the basis of how this literature has been analyzed, a limitations-focused systematic review is more readily structured around three distinct types of gap than around a single undifferentiated “limitations” section: coverage gaps (outcome domains, populations or settings that existing studies have not addressed, such as the motor/non-motor imbalance described above), validity gaps (where a measurement exists but its relationship to the clinical construct it is intended to represent is weak or unestablished, such as single-site sensor placement) and generalizability gaps (where validation conditions differ meaningfully from real-world use, such as clinic-based testing as opposed to unsupervised home use). Reporting each included study against all three types of gap, rather than noting only whether it found a positive result, converts a review from a summary of individual findings into a genuine map of where the evidence base for a technology is limited, which is the specific contribution that this kind of review is intended to make.
Documented gaps in care integration and telehealth delivery
A review of the limitations of this literature would be incomplete without a fourth type of gap, to be tracked alongside coverage, validity and generalizability: integration into routine care delivery. Dorsey and colleagues' review of telemedicine for Parkinson's disease care describes how even well-validated monitoring measures often remain disconnected from the electronic health records and care pathways that clinicians use in daily practice, which limits their practical impact regardless of their performance in validation studies8. Bloem and colleagues' proposed network model for reshaping chronic neurological care makes a related point from a health-systems perspective, arguing that the limitations of monitoring technology cannot be fully separated from the broader limitation of fragmented, specialist-centered care delivery for a chronic, fluctuating condition such as Parkinson's disease, and that evaluating a monitoring technology in isolation from the care model it is intended to support risks understating this structural gap9. A thorough limitations-focused review of this literature should therefore extract, in addition to the three types of gap already described, whether and how each included study addressed integration with existing clinical workflows, and not only its measurement performance in isolation.
Reporting gap findings in a usable form
The value of a gap-focused review is lost if its findings are reported only as a general statement that “further research is needed.” The more useful convention, consistent with how PRISMA 2020 asks authors to report synthesis results generally, is to state each identified gap as a specific, actionable research need, naming the exact outcome domain, population or setting that remains uncovered and, where possible, suggesting the minimum study design or measurement approach that would address it2. For the Parkinson's disease wearable-sensor literature, this might mean stating not simply that “non-motor symptoms are under-studied,” but that continuous, unobtrusive measurement of orthostatic hypotension and sleep fragmentation in community settings, validated against an ambulatory reference standard rather than a single clinic visit, remains largely absent from the published literature as of the studies reviewed. This level of specificity enables a funding body, a device manufacturer or a future research team to act directly on the findings of a gap-focused review, rather than treating them as a general closing caveat.
Key points
Key points
A review of a technology's limitations should map coverage, validity, and generalizability gaps across the whole evidence base, not just summarize individual study findings; the Parkinson's disease wearable-sensor literature is a well-documented case where motor symptoms are heavily validated while non-motor symptoms and real-world generalizability remain comparatively thin.
Practical application
Practical application
- Gap categories should be defined before data extraction begins. Reviewers should decide in advance whether coverage gaps, validity gaps, generalizability gaps or all three are to be tracked, so that the data extraction form captures the relevant variables from each included study.
- Unmeasured outcomes should be extracted alongside reported findings. For each included study, the plausible outcome domains, populations or settings that it did not address should be recorded, since a standard effectiveness extraction form typically omits this information.
- Gaps should be reported with the same structure as findings. Each identified gap should be stated specifically (domain, population and setting) rather than through a general closing statement that ‘more research is needed’.
Frequently asked questions
They overlap but are not identical. A scoping review typically maps the breadth of a literature without assessing study quality in depth; a limitations-focused review can use scoping methods but specifically organizes its synthesis around identified coverage, validity, and generalizability gaps rather than simply cataloguing what exists.
Several independent reviews, conducted by different research teams in different years, converge on the same motor/non-motor coverage imbalance, which is partly why it is a well-documented rather than a speculative example; the consistency across independently conducted reviews is itself evidence that the gap is genuine rather than an artifact of the search strategy of one research team.
Yes. The distinction between coverage, validity and generalizability is a general means of structuring any review focused on the evidence gaps of a field rather than its positive findings, and it has been applied in domains well beyond wearable health technology.
It depends on the chosen format: a systematic review following this approach typically still assesses the risk of bias of each study, since this informs how much weight the contribution of each study to a given gap deserves, whereas a scoping review under PRISMA-ScR is not required to assess risk of bias as rigorously, since its primary aim is to map breadth rather than to weigh evidence quality.
References
- Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12-13. read 10 October 2026. View on PubMed
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. read 10 October 2026. View on BMJ
- Espay AJ, Bonato P, Nahab FB, et al. Technology in Parkinson's disease: Challenges and opportunities. Mov Disord. 2016;31(9):1272-1282. read 10 October 2026. View on Movement Disorders
- Rovini E, Maremmani C, Cavallo F. How Wearable Sensors Can Support Parkinson's Disease Diagnosis and Treatment: A Systematic Review. Front Neurosci. 2017;11:555. read 10 October 2026. View on Frontiers in Neuroscience
- Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord. 2013;28(12):1628-1637. read 10 October 2026. View on Movement Disorders
- Del Din S, Godfrey A, Mazzà C, Lord S, Rochester L. Free-living monitoring of Parkinson's disease: Lessons from the field. Mov Disord. 2016;31(9):1293-1313. read 10 October 2026. View on Movement Disorders
- Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-473. read 10 October 2026. View on Annals of Internal Medicine
- Dorsey ER, Glidden AM, Holloway MR, Birbeck GL, Schwamm LH. Deploying telemedicine for the care of Parkinson's disease. Nat Rev Neurol. 2018;14(5):285-297. read 10 October 2026. View on Nature Reviews Neurology
- Bloem BR, Henderson EJ, Dorsey ER, et al. Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. Lancet Neurol. 2020;19(7):623-634. read 10 October 2026. View on The Lancet Neurology
- Espay AJ, Hausdorff JM, Sánchez-Ferro Á, et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies. Mov Disord. 2019;34(5):657-663. read 10 October 2026. View on Movement Disorders
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring. Pubrica. https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/
Pubrica Academy. “Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring.” Pubrica, 10 Oct. 2026, pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/.
Pubrica Academy (2026) Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring. Pubrica. Available at: https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/ (Accessed: 15 October 2026).
Pubrica Academy. “Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring.” Pubrica. October 10, 2026. https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/
Pubrica Academy, ‘Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/> accessed 15 October 2026.
Pubrica Academy. Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/
Pubrica Academy, “Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/
@misc{/la_systematic_review_limitations_parkinsons_monitoring_2026,
author = {{Pubrica Academy}},
title = {Writing a Systematic Review of a Technology's Limitations: Lessons from Parkinson's Disease Monitoring},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/systematic-review/a-systematic-review-on-the-limitations-and-challenges-of-parkinsons-disease/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Technology-Limitations Review Extraction Form
This checklist should be used alongside the standard data extraction form for a review focused on evidence gaps rather than effect sizes.
[ ] Outcome domain(s) this study measured [ ] Outcome domain(s) plausibly relevant but NOT measured in this study [ ] Population characteristics represented (and notably absent, e.g. age range, disease stage, setting) [ ] Reference standard or comparator used to validate the measurement, if any [ ] Conditions of validation: controlled/clinic-based vs. free-living/real-world [ ] Gap type(s) this study illustrates: coverage / validity / generalizability
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica's systematic review team builds gap-focused extraction forms and synthesis frameworks for reviews that aim to map a field's evidence limitations rather than pool a single effect estimate.